Related Experiment Video
Updated: Apr 1, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical
María Salud Abellán Ruiz1, María Dolores Barnuevo Espinosa1, Carlos J Contreras Fernández1
1Cátedra de Fisiología del Ejercicio. Facultad de Ciencias de la Salud, UCAM -Universidad Católica de Murcia, Campus de los Jerónimos, n° 135 Guadalupe, 30107, Murcia, Spain.
Resistant maltodextrin (RMD) significantly improved colonic transit time (CTT), stool volume, and consistency in healthy adults. This functional fibre enhances intestinal function without adverse effects.
Area of Science:
- Gastroenterology
- Nutritional Science
- Human Physiology
Background:
- Growing recognition of dietary fibre's importance fuels interest in functional fibre components.
- Digestion-resistant maltodextrin (RMD) is a functional fibre component with potential benefits for intestinal health.
Purpose of the Study:
- To evaluate the effects of RMD on colonic transit time (CTT).
- To assess RMD's impact on defecation characteristics, including frequency, stool volume, and consistency.
- To investigate RMD's influence on overall intestinal function in a healthy population.
Main Methods:
- A randomized, placebo-controlled, double-blind study involving 66 healthy adult volunteers.
- A 7-day run-in period followed by a 21-day intervention with RMD or placebo.
- Colonic transit time (CTT) and segmental CTT (SCTT) assessed via X-ray after radiopaque marker ingestion; defecation characteristics self-reported.
Main Results:
- RMD significantly decreased total CTT, left SCTT, and rectosigmoidal SCTT compared to baseline.
- The RMD group experienced a significant increase in stool volume (56% vs. baseline) and improved stool consistency.
- No adverse effects were reported in the RMD group, indicating good tolerability.
Conclusions:
- RMD effectively improves colonic transit time in healthy individuals.
- RMD enhances key defecation parameters, including stool volume and consistency.
- RMD demonstrates potential as a functional fibre to support intestinal health.
Related Concept Videos
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...

